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Highlights 
 Despite the established benefits of antimicrobial stewardship programmes in reducing 
inappropriate antimicrobial use and resistance, their adoption in Gulf Cooperation Council 
hospitals remains low 
 The adoption of antimicrobial stewardship programmes in hospitals in the region can be 
facilitated or hindered by a range of Institutional and individual factors 
 Six outcome measures to evaluate ASPs in GCC countries hospitals have been reported. 
These include:  reduction of inappropriate prescribing, reduction of healthcare-associated 
infections, reduction of direct antimicrobial cost, reduction of length of stay/ mortality 
metrics, reduction of antimicrobial resistance and reduction of broad-spectrum antibiotic 
use.  
 Hospital adoption of ASPs results in improvement in at least one outcome measure. 
 
Abstract 
Antimicrobial resistance is increasing at an alarming rate in The Gulf Cooperation Council (GCC) due to the over 
and misuse of antimicrobials. The novel and rare multi-drug resistant strains can spread globally since the region 
is a host to the largest expat population in the world and a pilgrimage destination to more than 4 million people 
annually. The adoption of antimicrobial stewardship programmes could improve the use of antimicrobials and 
reduce antimicrobial resistance in the region. However, despite the established benefits of these interventions, little 
is known about the level of their adoption in the region, and the impact of these programmes on antimicrobials use 
and resistance. This study aims to review the existing evidence on the level of adoption of antimicrobial stewardship 
programmes, the facilitators/ barriers to their adoption and the outcomes of their adoption in GCC hospitals. 
 
Keywords: Antimicrobial stewardship programmes; ASP; antimicrobial resistance; hospital; Gulf Cooperation 
Council  
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1. Introduction 
Antimicrobial resistance is a global public health concern undermining efforts to treat infectious diseases, resulting 
in increased morbidity and mortality, and adding avoidable costs to already strained healthcare systems [1]. Drug 
resistant strains of common bacterial infections, HIV, TB and malaria are causing the death of hundreds of 
thousands of people every year. It is estimated that mortality due to antimicrobial resistance will be the highest at 
10 million people a year, followed by cancer and other causes by 2050 [2,3].  
The burden of antimicrobial resistance continues to increase in the GCC region with reports of Extended Spectrum 
Beta-Lactamase (ESBL) producing bacteria, Carbapenemase producing bacteria, Pan-drug-resistant Gram-
negative bacilli and multi-drug-resistant tuberculosis [4–8]. Further, rare and novel resistant strains have also been 
reported, possessing blaOXA-48 type and blaNDM-1 carbapenemase associated with hospital outbreaks and increased 
mortality [9]. Antimicrobial resistance in the region is implicated in around 20% of paediatric haematology/ oncology 
patients’ deaths [10], 40% deaths in a tertiary hospital in the region [11] and 60-90% causes of ventilator-associated 
pneumonia that is resistant to most tested antimicrobials [6,12]. 
The high antimicrobial resistance rates in the region are accompanied with heavy international travel due to the 
large expatriate population in the region, booming tourism particularly in the United Arab Emirates (UAE), and the 
influx of more than 4 million pilgrims throughout the year to Saudi Arabia [4,13–15]. Population mobility has been 
suggested as a main factor in the globalisation of antimicrobial resistance through the distribution of antimicrobial 
drug–resistant organisms [16]. Tackling the issue of antimicrobial resistance in the region could prevent the 
emergence of novel multi-drug resistant strains and reduce the globalisation of this health threat. 
The misuse of antimicrobials is one of the main causes of antimicrobial resistance, and yet, around 20-50% of 
antimicrobials prescriptions are deemed unnecessary or inappropriate [17,18]. In the GCC region, retail trends of 
antimicrobials are high, and they continue to rise; retail increased from 27,844 in 2000 to 38,788 standard units per 
1000 population in 2015 in Saudi Arabia, UAE and Kuwait alone [19]. Most of this inappropriate antimicrobial usage 
occurs outside hospitals, where non-prescription access to antimicrobials in community is widely common in the 
region. However, interventions to improve antimicrobial usage and reduce antimicrobial resistance have widely 
focused on hospital settings. These interventions typically involve the adoption of antimicrobial stewardship 
programmes (ASPs).  
ASPs are collective strategies to enhance the appropriate use of antimicrobial agents, and minimise adverse effects 
and costs that may arise from their use. This is usually achieved through the selection of the right antibiotic regimen, 
correct dose, duration of use, and how a given agent is administered. ASPs core strategies include; prospective 
audit with intervention and feedback (back-end strategy), and formulary restriction and preauthorisation (front-end 
strategy). Supplemental strategies include: education, streamlining/timely de-escalation, dose optimization, 
parenteral to oral conversion, antimicrobial order forms, combination therapy, computer surveillance and decision 
support, guidelines and clinical pathways, and automatic stop orders [17,20,21].  
The published hospitals experience on the adoption of ASPs is vast, especially in large and tertiary hospitals [22–
25]. However, little is known about the level of adoption of these programmes in hospitals in the GCC region. The 
recent review by Nasr et al.  [26] is the first attempt to explore existing ASPs in the Middle East, including in member 
states of the GCC. However, details of these existing ASPs, barriers and facilitators to their adoption, and the 
impact of their adoption on patient and institutional outcomes are yet to be established. Understanding the current 
picture of ASPs in GCC hospitals is imperative to draw upon the current experience and design and adopt more 
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effective ASPs. Therefore, this study seeks to address this gap by exploring the level of adoption of ASPs, the 
facilitators/ barriers to their adoption and the outcomes of their adoption in GCC hospitals. 
 
2. Methods 
2.1 Search Strategy 
We searched the electronic databases of PubMed (MEDLINE), Embase, Scopus, CINAHL Plus, Ovid, Goole 
scholar, grey literature, and official health authorities’ websites for each GCC country (Bahrain, Kuwait, Oman, 
Qatar, Saudi Arabia, United Arab Emirates), from 01/1981 to 07/2017. References lists of retrieved articles and 
relevant review articles were checked manually for further relevant studies. Table 1 shows the search terms that 
were used. The search terms in the same group were combined using the Boolean term OR, while the three groups 
of search terms were combined using the Boolean term AND. 
 
2.2 Study Selection 
Search results were exported to Mendeley®, a free reference manager and academic social network (Elsevier). 
Titles, abstracts and articles were reviewed. We included studies that met the following criteria: 1) conducted in 
any of the GCC countries; 2) reported ASP in a hospital setting; 3)reported a national ASP/AR policy; 4) published 
between 01/1981 and 07/2017; and 5) published in English and/or Arabic language. We excluded studies for the 
following reasons: 1) ASPs in primary healthcare centres, dental centres, cancer centres, and community 
pharmacies; 2) only reported consumption and resistance rates; or 3) conducted in animals. Since this is an 
exploratory study, there was no restriction on the type or quality of studies included in the review. 
Two authors screened all titles and abstracts independently to determine whether the article met the inclusion 
criteria and should be retrieved. A third author screened a random 10% sample to check the reliability of the 
screening. Any discrepancies were resolved through discussion between the authors. Two authors then read and 
extracted data from the articles included in this review. 
We also explored grey literature to broaden the scope of evidence and provide a more complete picture on the 
level of ASPs adoption in GCC countries hospitals, barriers and facilitators to ASPs adoption and the outcomes of 
their adoption.  
 
2.3 Data Abstraction & Synthesis 
We extracted data on study type, reported ASP, components of the reported ASP, and ASP team members to 
establish the nature of the evidence, the level of ASP adoption in GCC hospitals, the commonly adopted ASP 
strategies and the healthcare professionals involved in ASP adoption and implementation. Further, we extracted 
data on barriers and facilitators to ASP adoption if reported, and ASP outcome measures to highlight the impact of 
ASP adoption on antimicrobial use and resistance in GCC hospitals. Discrepancies were resolved by consensus.   
We presented the evidence in tables showing the country, year of publication, study type, existing ASP, 
components of ASP, ASP team members, and facilitators and barriers to ASP adoption if reported. We also 
presented ASP outcomes showing: reduction of inappropriate prescribing, reduction of healthcare-associated 
infections, reduction of direct antimicrobial costs, reduction of length of stay/ mortality metrics, reduction of 
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antimicrobial resistance and reduction of broad-spectrum antibiotic use. We summarised our findings and drew 
conclusions based on a qualitative synthesis of the data. 
3. Results 
We reviewed 2,801 titles and abstracts from the literature search. Nine hundred and sixty-two duplicates were 
removed. We excluded 1740 after title review, 48 after abstract review and 27 after full text review, leaving twenty-
four articles eligible for inclusion. Grey literature searching identified seven conference publications, and two 
national ASP/AR policies, totaling 33 included papers. Figure 1 illustrates the literature review process. 
 
The retrieved studies reported evidence of ASPs in all GCC countries, including 13 reports from Saudi Arabia, 5 
reports from Qatar, 4 from Bahrain, 4 from Oman, 3 reports from Kuwait and 2 reports from UAE. We also identified 
two national strategies/guidelines relating to antimicrobial resistance and stewardship at GCC level, and in Saudi 
Arabia. 
 
3.1 Existing hospital ASPs in GCC countries  
We identified evidence of existing ASPs in hospitals in all GCC member states. Saudi hospitals reported the highest 
level of adoption of ASPs in GCC, followed by Qatar, Oman, Bahrain, Kuwait and UEA respectively. Very little 
evidence was retrieved from UAE including one study and data from a conference presentation highlighting the 
lowest level of adoption reported in the region. Further, although Saudi Arabia reports the highest level of adoption 
of ASPs compared to other hospitals in the region, ASPs are currently mainly adopted in tertiary hospitals and big 
medical cities. In Qatar, there is evidence of existing ASPs in tertiary hospitals and community hospitals. Most 
studies from Oman report existing ASPs in tertiary hospitals, particularly, Sultan Qaboos Hospital. All ASPs 
reported in Bahrain have been adopted only in military hospitals. In Kuwait, only one study involving nine 
government hospitals has been retrieved. The remaining evidence relate to efforts of the directorate of infection 
control in the Kuwait Ministry of Health (MOH) to raise awareness of antimicrobial resistance amongst healthcare 
professionals, patients and the public. 
We also identified a strategic plan for combatting antimicrobial resistance in GCC States, which was introduced in 
2015 in response to the rising rates of antimicrobial resistance [27]. This is an overall framework to address the 
problem of resistance in the region, and each member state is expected to formulate their action plan according to 
their local resistance data and public health resources.  
We highlight that Saudi Arabia is so far, the only member state to draft a national ASP plan as part of a reformed 
overall MOH strategic plan [28,29]. Other member states still lag behind lacking national plans for detecting and 
reporting antimicrobial resistance, and national plans for antimicrobial stewardship. 
Our findings indicate that most ASPs in the region are adopted in tertiary hospitals (Oman, Saudi Arabia and United 
Arab Emirates) and military hospitals in Bahrain and Saudi Arabia. We found that the main antimicrobial 
stewardship strategies reported in GCC countries hospitals are antimicrobial guidelines implementation, audit and 
feedback, and formulary restriction and pre-authorisation.  Other antimicrobial stewardship initiatives include: 
clinical practice guidelines, IV to oral step-down guidelines, education activities for healthcare professionals and 
patients, de-escalation protocols, monitoring adherence to protocols and guidelines.  
Little evidence related to antimicrobial resistance surveillance and reporting, as well as their integration within 
antimicrobial stewardship initiatives at hospital level was found. The only evidence relates to a national campaign 
by Kuwait’s directorate of infection control in 2012 to raise awareness of antimicrobial resistance among healthcare 
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professionals, patients and the public [30]. Moreover, this initiative has not been duplicated in Kuwait or other GCC 
member states.  
We explored the involvement of healthcare professionals as part of ASP teams, and we found that most ASP teams 
only include ID consultants and physicians, physicians, and to a lesser extent infection control specialist nurses. 
Occasionally, pharmacists were involved in monitoring antimicrobial consumption, and reporting and providing 
feedback on antimicrobial prescribing practices. Microbiologists appear to only be occasionally involved in 
somewhat advanced antimicrobial stewardship practices tailoring stewardship interventions around local 
antimicrobial resistance data (studies from Saudi Arabia). Further, only Saudi Arabia appear to embrace the role 
of clinical pharmacists in stewardship initiatives; those are pharmacists with a post-graduate clinical diploma and 
advanced competence in infection control and antimicrobial stewardship.  
Several studies did not provide details on the involvement of ASP teams, and occasionally, only referred to 
antimicrobial subcommittees that are usually a subcommittee of drug and therapeutic committees. 
Our findings in relation to the evidence of existing ASPs, components of ASPs and ASP team members are 
presented in table 2. 
 
3.2 Barriers and facilitators to ASPs adoption in GCC hospitals 
Nine of the 35 retrieved reports addressed barriers and/or facilitators to ASPs adoption (evidence summarised in 
table 3). These factors can be either individual or institutional. At an individual level, physicians are naturally the 
main prescribers in the hospital setting. They reported the following barriers to ASP adoption in their practice 
setting: lack of up-to-date knowledge regarding appropriate antimicrobial use and resistance, lack of confidence in 
the currency of the hospital antimicrobial policies and guidelines and their unavailability/ inaccessibility, prescribing 
norms and reluctance to prescribe antibiotics other than their “usual”, lack of knowledge/ experience regarding 
ASPs, lack of time to perform the required investigations, fear of patient’s complications and their hesitance to de-
escalate antimicrobial therapy in very sick patients or patients at risk of sepsis. At hospital level, the following were 
reported as barriers to adopting ASPs: lack of expertise such as infectious diseases specialists, unavailability/ 
interrupted supply of antibacterial, lack of education and training events regarding appropriate antimicrobial use 
and resistance, lack of microbiology resources and if found, lack of their integration into antimicrobial policies and 
stewardship programmes, and lack of administrative/ management support. One hospital in Makkah, Saudi Arabia, 
specifically referred to the annual Hajj event and the challenges it brings to maintaining adequate control over 
antimicrobial use and resistance due to increased hospital admission rates and subsequent increase in 
antimicrobials use [50]. Another tertiary hospital in Saudi Arabia conferred increased resistance rates in the hospital 
to the high prevalence of antimicrobial resistance in other hospitals in the country and the subsequent transfer of 
resistance to the specialist hospitals upon admission for last resort interventions [58]. Noteworthy, lack of funding 
for ASPs and initiatives, which is often determined by ministry of health at government level, was also reported as 
a barrier to adopting antimicrobial stewardship in hospitals.  
Evidence on the facilitators of hospital adoption of ASPs is little. The Kuwaiti infection control directorate advocates 
that prescribers’ experience (in relation to age) and knowledge of antimicrobials can lead to good antimicrobial 
stewardship [30]. It was found that Omani hospitals that had a consistent, written and accessible antimicrobial 
policy had better outcomes in relation to post-operative infections [37]. A Saudi study suggests that discussing 
evidence of antimicrobial stewardship interventions with prescribers and supporting them could reduce prescribers 
concerns regarding adoption and implantation of ASPs interventions. Further, the authors suggest that engaging 
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directly with targeted (main) prescribers and influential practitioners (such as consultants) could encourage 
physicians to support ASP initiatives [51]. The barriers and facilitators to ASPs adoption in GCC countries hospitals 
are presented in table 3. 
 
3.3 Outcomes of hospital adoption of ASPs in GCC countries 
We identified six outcome measures to evaluate ASPs in GCC countries hospitals. These include: reduction of 
inappropriate prescribing, reduction of healthcare-associated infections, reduction of direct antimicrobial cost, 
reduction of length of stay/ mortality metrics, reduction of antimicrobial resistance and reduction of broad-spectrum 
antibiotic use.  
Most studies in all GCC states reported improvement in at least one outcome measure as a result of adoption of 
ASP. Studies in Saudi hospitals mostly used more than one outcome measure to assess effectiveness of ASPs 
interventions. Studies in the remaining GCC states mainly assessed the impact of ASPs on the reduction of 
inappropriate prescribing. Noteworthy, only two of the 31 retrieved studies (in Saudi Arabia) measured the impact 
of ASPs on antimicrobial resistance rates. 
The adoption of ASPs and initiatives in GCC states hospitals has reportedly resulted in reduction of inappropriate 
prescribing especially when adherence to antimicrobial policies and clinical guidelines was enforced and monitored. 
A Qatari study reported that only 40% of surgical patients received the correct antibiotic due to lack of adherence 
to antimicrobial policies and guidelines [42]. A study in UAE reported a low 32% adherence to guidelines resulting 
in appropriate antimicrobial prescribing [60]. A Saudi study reported that education and feedback to prescribers 
improved adherence to antimicrobial guidelines from 35% to 68% [47]. 
Reduction in healthcare associated infections was not frequently measured in the reported studies. We retried six 
studies (4 from Saudi Arabia, 1 from Oman, and 1 from UAE) reporting reduced post-operative infections, and 
reduced peri-operative infective complications from 32% to 11% in one study [46]. Two out of three studies reported 
reduction in C.diff infection rates [51,59] whereas one Saudi study found no impact on this measure [48]. 
Direct antimicrobial costs are rarely measured in the included studies. Saudi Arabia appear to be the most 
advanced in the adoption of ASPs and four studies from hospitals report cost reduction of up to half as a result of 
ASPs adoption and implementation [48–50,57]. The only other study comes from UEA and reports 40% in 
antimicrobials consumption and associated costs [59]. 
Only three studies reported on the impact of ASPs on length of stay and/ or mortality metrics [31,32,48]. Bahrain 
studies on adoption of ASPs in the outpatient department of a military hospital reported that the outpatient service 
prevented admissions to hospital (2 out of 101 in 2013 and 6 out of 97 in 2015) as a result of their antimicrobial 
stewardship practices [31,32]. Another study in a Saudi hospital reported reduction of hospital stay to 376 defined 
daily doses (DDD) compared to 2404 DDD pre-ASP adoption [48]. The study further reported a decrease in 
mortality rate from 33% to 17%. 
Given the modest engagement of microbiologists in the ASPs and initiatives reported, it is not surprising that most 
studies neglect to measure/ report the impact of ASPs on antimicrobial resistance rates. One Saudi study reported 
reduction of antimicrobial resistance from some organism-antibiotic combinations, but an increase in resistance to 
other antibiotics that were heavily used as an alternative including piperacillin/ tazobactam [51]. Another Saudi 
study reported that their hospital ASP had no impact on resistance rates [58]. The only other report is a reduction 
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in multi-drug resistance rates in a UAE hospital, and was obtained from an oral presentation at the international 
conference on antimicrobial stewardship in Saudi Arabia [59]. 
The use of broad-spectrum antibiotics remains a challenging practice in GCC hospitals. Studies from all states 
measured the impact of ASPs adoption on use of broad spectrum antibiotics and only one Qatari study reported a 
reduction in the use of cefuroxime [45]. It was further reported in another study that the decline in using 
cephalosporins was accompanied with a rise in using other antibiotics such as pencillins and IV macrolides [44]. 
Two studies from Bahrain reported increased use of broad spectrum antibiotics like ceftriaxone due to resistance 
to first and second line options [31,32]. One Omani study reported that 90% of antibiotic prescriptions were for 
broad spectrum antibiotics due to lack of adherence with antimicrobial guidelines and policies [40]. An oral 
presentation in 2013 also reports a decline in using broad-spectrum antibiotics in an UAE hospital as a result of 
antimicrobial stewardship interventions in that setting [59]. The reported outcomes of ASPs adoption in GCC 
countries hospitals are presented in table 4.  
 
4. Discussion 
We explored the evidence on ASPs' adoption, barriers and facilitators affecting their adoption, and the outcomes 
of their adoption in hospitals in all six-member states of the GCC. Our findings suggest that hospitals in the region 
have adopted fragments/ initiatives of ASPs. This is consistent with the recent review findings of the impact of 
ASPs on antibiotic appropriateness and prescribing behaviours in selected countries in the Middle East [26]. 
Although the GCC strategic plan to combat antimicrobial resistance is still at its infancy [27], it is nonetheless, the 
first step towards establishing common ASPs across the region, taking advantage of the common geographic, 
economic and social characteristics amongst the member states; similar to the example of the European Union 
adoption of ASPs in hospitals in 2006 [61].  
The main antimicrobial stewardship strategies reported in GCC countries hospitals are antimicrobial guidelines 
implementation, audit and feedback, and formulary restriction and pre-authorisation. These strategies are 
commonly employed as part of ASPs adoption, and have been identified in previous systematic reviews as common 
practice [26,62].  
We identified that the barriers to adopting ASPs in GCC countries hospitals are mostly physician related, and that 
the challenges can be further exacerbated by lack of leadership and support by hospital management. Hajj poses 
a specific threat to antimicrobial stewardship adoption and implementation especially in hospitals in Saudi Arabia. 
The sheer volume of pilgrims leads to increased hospital admissions, increased antimicrobial consumption, and 
increased risks of resistance development and transmission to other healthcare facilities in the country [50]. 
Further, ASPs reported in GCC hospitals are mostly led by Infectious Diseases (ID) physicians and consultants; 
they are a key determinant/ facilitator to adoption and success of ASPs interventions. Interestingly, one of the main 
reported barriers to ASPs adoption in GCC hospitals is the lack of ID consultants and microbiologists. Currently, 
there are 57 ID physicians (Tropical medicine) (25 registrars and 32 consultants) in Saudi MOH hospitals (274 
hospital) [63]. Factors contributing to the low numbers may include unattractive working condition and low 
remuneration in comparison to private sector [64]. This situation is not unique to GCC countries, as reports by 
[65,66] show that only 50-58% of smaller US hospitals have access to ID physicians. 
Microbiologists and ID specialists are leading ASPs team members, but they also require the help of hospital 
pharmacists to monitor patterns of drug use in the various clinical departments, enabling analysis and feedback to 
prescribers and providing expert advice about antimicrobials [67]. In this review, we highlight the lack of involvement 
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of other healthcare professionals such as clinical pharmacists in ASPs teams, ASPs design and implementation. 
This is a missed opportunity to enhance antimicrobial stewardship especially since evidence point to the importance 
of multi-disciplinarily to improve timeliness and appropriateness of antimicrobial therapy [68,69]. 
We also identified individual and institutional factors relating to culture and resources. Physicians referred to their 
knowledge, prescribing behaviour, workload, and fear of blame if patients deteriorate upon changing antimicrobial 
therapy. Hospitals lack IT infrastructure, human and financial resources, leadership support and effective 
communication channels. These factors and others have been extensively reviewed by [70] and highlighted in  a 
qualitative study in 2014 [71]. Further, a recent systematic review suggests that hospitals in the region may not 
foster an open, blame-free culture where reporting and learning from errors is encouraged [72]. In that, prescribers 
do not routinely adhere to antimicrobial prophylaxis guidelines, with treatments routinely extending beyond the 
suggested three days recommendation; in order to reduce the risk of complications and patients’ deterioration, and 
the subsequent blame. 
Facilitators to ASPs adoption in GCC countries hospitals include: prescriber’s knowledge and experience, clear, 
accessible and consistent antimicrobial policies and open, face-to-face communication and feedback on 
prescribing patterns. These findings are consistent with previous findings by [73,74], highlighting the importance of 
experienced physicians and ID leadership and expertise, and engagement with clinicians to improve antimicrobial 
use. 
The benefits of antimicrobial stewardship adoption in healthcare settings are well-established including improving 
appropriate antimicrobial use [24], reducing emergence of antimicrobial resistance [25] and reducing associated 
healthcare costs [23]. Here, we found that the reported ASPs in GCC countries hospitals, although small-scaled 
and not sophisticatedly-designed, led to improved antimicrobial prescribing practices and better patient outcomes, 
especially when adherence to ASPs guidelines is enforced and monitored. Lack of adherence (or lack of) to 
antimicrobial guidelines continues to be a challenge world-wide. Various studies have shown that the adherence 
to guidelines is suboptimal in many hospitals [75,76]. The role of pharmacists in monitoring guidelines adherence 
and providing feedback to prescribers has been strongly advocated as a means to improving adherence and 
subsequently, ensuring appropriate antimicrobial prescribing [77].  
Despite the established evidence of reducing antimicrobial resistance [25,78,79], we found very little evidence of 
this in GCC hospitals. Firstly, we found that reduction of antimicrobial resistance rates was not a frequently 
measured outcome. This is consistent with findings of an earlier systematic review [62] that they retrieved six 
studies that reported the impact of antimicrobial stewardship on resistance rates reporting reduction in certain 
resistant strains and increased rates of others [62]. Secondly, we found that there was either no effect on resistance 
rates or a reduction in resistance for certain organism-antibiotic combinations and a rise for other organism-
antibiotic combinations. This could be because the interventions are poorly designed resulting in reduced 
prescribing of certain antibiotics but a parallel rise in prescribing alternative antibiotics, and the scarcity/ lack of 
integration of microbiology services in designing and implementing ASPs in hospitals. Further, microbiologists in 
the region report a lack of a standardised method for phenotypic and genotypic methods for antimicrobial 
susceptibility testing, and the sporadic and inconsistent reporting of antibiotic resistance bacteria; when 
antimicrobial resistance surveillance is conducted, it is typically in laboratories of large hospitals that are not linked 
within a national network [80]. 
Limitations and future research 
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Although the previous review by Nasr et al (2017) explored the antimicrobial stewardship practices in the region, 
this is the first comprehensive review of evidence on hospital adoption of ASPs in GCC countries. We reviewed 
published evidence from a variety of study types, programme goals and outcomes. We also collected grey literature 
to broaden the scope of evidence and provide a more complete picture on the level of ASPs adoption in GCC 
countries hospitals, barriers and facilitators to ASPs adoption and the outcomes of their adoption. However, most 
of the studies neglected to define ASPs and their details. Further, methodological limitations were noted in the 
available evidence, including validity, and unmeasured or unreported changes as a result of ASP adoption. Also, 
the reviewed studies were small, and with short or no follow-up period. Larger pre-and post-studies with longer 
follow up periods are required to effectively evaluate antimicrobial stewardship interventions in the region and 
demonstrate how challenges to their successful adoption could be overcome. We also urge researchers and 
clinicians in the region to provide more detailed reporting of ASPs adoption and evaluation in relation to adopted 
ASP strategies and the various outcomes to measure ASPs impact on antimicrobials use and resistance. 
Our findings highlight the existing initiatives in the region in secondary care, but further research is also required to 
explore the misuse of antibiotics over the counter and the potential adoption of antimicrobial stewardship in 
community pharmacy and primary care. 
Implications for practice 
For policy makers 
The adoption of ASPs in hospitals in GCC member states remains low due to a variety of individual and institutional 
barriers. A national strategy regarding antimicrobial stewardship for local implementation is essential to drive 
forward the efforts to curb inappropriate antimicrobial use and reduce resistance [27,81]. Further, any national 
antimicrobial strategy should contribute to the overall regional targets of reducing resistance and improving 
antimicrobials use, especially since GCC member states collaborate extensively in relation to healthcare services, 
allow free movement of persons, and share characteristics of geography, culture, and economic resources. 
Although GCC has recently developed an antimicrobial resistance strategic plan in 2015 [27] following the example 
of European Union [61] and the WHO One Health model [81]. The plan is still at its infancy, and so far, only Saudi 
Arabia has a national ASP policy, with communications from MOH to MOH hospitals to encourage adopting ASPs 
since 2014 [28,29]. Since private hospitals and primary care centres are yet to engage with this initiative, 
antimicrobial stewardship strategies should be more inclusive. Further, regulation and inspection could improve 
enforceability of policies.  
For healthcare institutions 
The literature on adoption of ASPs provides a detailed map of how hospitals could adopt this practice. Further, 
facilitating and sharing regional experiences of adoption from Saudi Arabia could improve organisational learning.  
For successful ASPs adoption, hospital leadership is paramount to ensuring implementation and enforcement of 
guidelines and recommendations in collaboration with clinicians and other stakeholders. Further, providing 
education and training on appropriate antimicrobial use and resistance, as part of the medical curriculum and 
continuing professional development, can improve healthcare professionals’ adoption of antimicrobial stewardship 
practices.  
Conclusion 
Antimicrobial resistance in the region is developing very rapidly, with alarming reports of novel and rare multi-drug 
resistant strains. There is a strong body of evidence supporting the benefits of ASPs in reducing resistance and 
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sustaining appropriate antimicrobials use. Despite the well-established benefits of ASPs adoption in healthcare 
settings, adoption in hospitals in GCC states remains low and underreported. The lack of national strategies to 
tackle antimicrobial resistance further hinders its local implementation. Reporting of antimicrobial resistance should 
be consistent and prompt as part of a national surveillance programme, and this resistance data should be included 
in the design and implementation of ASPs in hospitals in the region, with a strong multi-disciplinary engagement of 
healthcare professionals, and continuous collaboration with management at local and strategic levels. 
Nevertheless, the current state of antimicrobial resistance in the region warrants urgent action from governments 
and institutions. 
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Figure 1: Literature review flow chart of data extraction and study selection process 
 
  
Studies identified through 
database searching = 2801 
Studies screened for title = 
1839 
Studies abstract evaluated = 
99 
Full articles evaluated = 51 
Included articles = 24 
Included papers = 33 
Studies removed after applying limits and duplicates = 962 
Studies excluded after title screening = 1740 and included:  
Studies not relevant to ASP and antibiotics (e.g: management of 
hepatitis, asthma, diabetes, arthritis, acne, hypertension, 
meningitis, malaria, pneumonia and tuberculosis) = 1253 
Studies reporting patterns of AR rates = 253 
Studies reporting patterns of antibiotic use/misuse = 115 
Studies about antibiotic use/misuse not in GCC countries = 65 
Studies reporting antibiotic use/misuse in primary/community or 
dentistry settings = 54 
  
48 articles were removed after abstract screening as they were: 
Studies reporting patterns of AR rates = 23 
Single Antibiotic intervention not part of ASP = 9 
Studies about antibiotic use/misuse not in GCC countries = 7 
Studies about antibiotic use/misuse in community/primary care = 6 
No access to full article = 3 
  
27 articles were removed after evaluating full text as they were: 
Studies evaluating/reporting antibiotic use/misuse= 14 
Studies not in GCC countries = 8 
Single Antibiotic intervention not part of ASP = 5 
  
Grey literature: 7 papers 
National ASP/AR policies: 2 
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Table 1 Search terms 
Antimicrobial stewardship programme 
terms 
Strategies terms Gulf Cooperation Council 
terms 
 
Antimicrobial stewardship program(s), 
Antimicrobial stewardship programme(s), 
Antimicrobial stewardship, Antimicrobial 
control program(s), Antimicrobial control 
programme(s), Antimicrobial management, 
Antimicrobial stewardship model, Antibiotic 
stewardship program(s), Antibiotic stewardship 
programme(s), Antibiotic stewardship, 
Antibiotic control, Antibiotic management 
   
 
Strategy (s), measure (s), 
intervention(s), policy (s), 
practice (s), protocol (s), 
surveillance, procedure (s), 
implementation, adoption, 
recommendation 
 
Gulf Cooperation Council, Gulf 
countries, GCC, Bahrain, 
Kuwait, Oman, Qatar, Saudi 
Arabia, United Arab Emirates 
(UAEs).  
 
  
AC
CE
PT
ED
 M
AN
US
CR
IPT
18 
 
 
Table 2: Evidence of ASPs in GCC hospitals 
Country Authors Setting Study Type Existing ASPs Components of 
ASPs 
ASP Team 
Bahrain Al Ansari et al., 2013 
[31] 
Outpatient setting 
attached to Bahrain 
Military hospital 
Audit of 
antimicrobials used, 
patients treated, 
patient satisfaction 
and total costs 
comparison 
Strategy to reduce 
the risk of healthcare 
associated infections 
and patients' length 
of stay 
Outpatient parenteral 
antimicrobial therapy: 
Treatment policy and 
protocol 
ID physician, Chief 
resident family 
physician, specialist 
nurse, pharmacist 
Al Alawi et al., 2015 
[32] 
Outpatient setting 
attached to Bahrain 
Military hospital 
retrospective review 
of case notes of 
patients admitted to 
OAPT clinic 
Strategy to reduce 
the risk of healthcare 
associated infections 
and patients' length 
of stay 
Establishing guideline 
and protocol of 
ceftriaxone use in 
OPAT treatment 
policy and protocol. 
No involvement of 
antibiograms 
ID consultant, family 
physician and 
specialist nurse 
Alqahtani, 2015 [33] 
(Conference 
presentation)  
400-bed defence 
force hospital 
Before/after study Strategy to reduce 
Multi-drug resistance 
bacteria and antibiotic 
consumption  
Formulary restrictions 
and preauthorization, 
local antibiotic 
susceptibility 
antibiogram, 
parenteral to oral 
conversion, guideline 
and clinical pathways, 
antibiotic audit with 
intervention and 
feedback, education 
AMS teams and 
committees 
World Health 
Organisation, 2016 
[34] (WHO report) 
Country's 
preparedness and 
capacities 
International mission 
report 
Hospitals have 
various elements of 
ASPs since 2012.                              
No national plan for 
detection and 
reporting of AMR 
pathogens or 
infections. No 
national plan for 
ASPs at central or 
facility level. No 
centres implementing 
ASPs.  No ASPs exist 
in private hospitals or 
primary care centres 
AMS teams and 
committees, 
antimicrobial use 
guidelines, and staff 
training. Strong 
NHRA control 
(National Health 
Regulatory Agency). 
AMS teams and 
committees 
Kuwait Al Mousa & Aly, 2012 
[35] 
The Directorate of 
Infection Control in 
Kuwait organised a 
national campaign to 
encourage judicious 
use of antibiotics in 
healthcare settings 
during the period 19–
26 March, 2009 
Letter to editor and 
campaign report on 
ministry of health 
website 
Campaign to raise 
awareness of 
doctors, pharmacists, 
patients and the 
public regarding 
appropriate 
antibiotics use called: 
‘Wise use or lose’ . 
Education activities to 
healthcare 
professionals, patient 
and public. Reminder 
SMS communication 
to Drs to use 
antibiotics wisely. 
Posters displayed on 
hospital corridors 
Organised by 
National directorate 
of infection control, 
Scientific and 
Awareness 
committee. No 
involvement of teams 
within hospitals in 
design 
Aly et al., 2012 [36] 9 government 
hospitals 
Audit of medical 
records in 9 
government hospitals 
assessing adherence 
to hospital antibiotic 
policy 
National antibiotic 
policy printed and 
distributed in booklets 
to hospitals since 
2007. Hospitals use 
the national policy as 
basis for their local 
antibiotic policy. 
Existing antibiotic 
policy and guidelines 
at national and local 
levels.  
Antibiotic policy 
contains broad 
evidence-based 
guidelines for the 
prescription of 
antibiotics to ensure 
appropriate 
prescribing 
Organised by 
National directorate 
of infection control, 
Scientific and 
Awareness 
committee. No 
involvement of teams 
within hospitals in 
design 
Kuwaiti Infection 
Control Directorate, 
2014 [30] 
(Government online 
report) 
Nationwide 
Campaign including: 
Audits of adherence 
to national/ hospital 
antibiotic policy (first 
one reported by Aly, 
2012. National 
awareness 
campaigns (1st one 
reported by Al-
Moussa & Aly, 2012). 
Campaign on 
antimicrobial 
resistance and 
judicious use 
targeting doctors in 
the private sector  
Antibiotic policy, 
audits of adherence 
to policy. National 
awareness 
campaigns Education 
workshop 14/11/12 to 
private sector and 
campaign activities in 
government hospitals 
and primary care 
centres 
Antibiotic policy                      
Audits of prescribing 
and adherence to 
policy 
Organised by 
National directorate 
of infection control, 
Scientific and 
Awareness 
committee. No 
involvement of teams 
within hospitals in 
design 
Oman Gunn et al., 2009 [37] Four major hospitals Retrospective 
examination of 
medical records of 
patients admitted for 
Lower Segment 
Caesarean Sections 
(LSCS) 
The Ministry of Health 
Antibiotic 
Chemotherapy Policy 
& Guidelines were 
published in 1998 
and cover the use of 
antibacterials in 
prophylaxis and 
treatment 
most major hospitals 
in Oman have 
established their own 
“in house” guidelines 
for almost all 
antibiotic 
use 
 
Al-Abri et al., 2012 
[38] 
 
Tertiary hospital 
(Royal Hospital) 
Muscat 
Retrospective case 
study involving a 
review of case notes 
of 342 patients 
CAP guidelines  Guidelines and 
antimicrobial use 
policy 
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Za'abi et al., 2013 
[39] 
Tertiary hospital 
(Sultan Qaboos 
university hospital) 
A review of patients' 
medical records of 
365 patients 
Antibiotic handbook 
(antibiotic policy) 
produced by the 
hospital in 2006 is the 
primary antibiotic 
protocol                   
Restricted Antibiotic-
Vancomycin 
Antibiotic policy/ 
guidelines and 
restricted antibiotics 
 
Al-Maliky et al., 2017 
[40] 
Tertiary hospital 
(Sultan Qaboos 
University hospital) 
Observational study 
involving 366 patients 
Local infections 
guidelines and 
Restricted antibiotic 
policy 
Antimicrobial 
guidelines      
restricted antibiotic 
policy 
 
Qatar Khan et al., 2010 [41] Tertiary hospital 
(Hamad General 
Hospital) 
Retrospective audit of 
medical records of 69 
patients 
Local infection 
guideline: Guidelines 
for management of 
CAP 
local infection 
guideline 
 
Abdel-Aziz et al., 
2013 [42] 
Tertiary hospital 
(Hamad General 
Hospital) 
Retrospective 
analysis of patient 
data from different 
surgical units in 
hospital  
Surgical antimicrobial 
prophylaxis 
guidelines 
Antimicrobial 
guidelines 
 
Pawluk et al., 2015 
[43] 
 primary/ community 
and secondary care 
Cross-sectional 
survey targeting all 
pharmacists 
practicing in Qatar 
Various ASP 
strategies reported by 
pharmacist in 
secondary care in 
Qatar 
Formulary restriction 
of antibiotics, clinical 
practice guidelines for 
infectious diseases, 
audit and feedback, 
IV to oral step-down 
guidelines, patient 
education, prescriber 
education, protocols 
that transfer authority 
from prescribers to 
pharmacists, 
antimicrobial cycling 
Pharmacists review 
medication and 
feedback to 
prescribers 
Garcell et al., 2016 
[44] 
 
Community hospital 
(75-bed facility) 
Observational study 
monitoring antibiotic 
consumption and 
compliance with 
policies (2012-2015) 
Hospital has an 
established ASP 
programme                                                
Current strategies for 
ASP in hospital 
Antimicrobial 
prescribing policy for 
therapeutic use and 
surgical prophylaxis 
including antibiotic 
stop orders, switching 
from IV to oral 
antibiotics and 
antibiotic restriction. 
Prescribing audits, 
antimicrobial 
consumption 
monitoring, feedback 
to medical staff and 
management, data 
dissemination, staff 
training and 
development. 
pharmacists monitor 
consumption and 
disseminate rates to 
medical and 
management staff. 
Infection prevention 
and control 
committee working 
closely with Quality 
and Patient Safety 
committees. 
Garcell et al., 2016 
[45] 
Community hospital 
(2013-15) 
Interventional study 
to determine the 
impact of ASP on 
antimicrobial related 
activities in hospital 
Existing, fully 
functional ASP 
focusing on 
appendectomies with 
quality indicators 
(compliance with 
timing, selection and 
dose, discontinuation 
of antibiotic 
prophylaxis as per 
protocol).                   
Staff education, 
monitoring 
antimicrobial 
consumption and 
providing feedback to 
prescribers 
Compliance with 
antibiotic prophylaxis 
was monitored by an 
infection control 
practitioner. 
Monitoring of 
antimicrobial 
consumption was 
monitored by 
pharmacists.  
Saudi 
Arabia 
Jacobs et al. 2003 
[46] 
Riyadh Armed forces 
hospital 
Interventional study 
involving 228 patients 
admitted to Intensive 
Care Unit for 
Percutaneous 
Dilatational 
Tracheostomy 
Antibiotic protocol 
and procedure 
guidelines 
Microbiology/ 
antibiotic protocol 
 
Dib et al., 2009 [47] Tertiary hospital 
Dhahran Health 
Centre 
Interventional study 
with reviews of 
medical records pre-
and post-intervention 
Hospital infection 
control practices 
advisory committee 
producing 
antimicrobial use 
guidelines, education 
and feedback 
antimicrobial use 
guidelines, education 
and feedback 
Clinical pharmacist 
review and feedback 
to prescriber 
regarding adherence 
to guidelines. 
Infectious disease 
consultants used in 
persistent use cases 
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Amer et al., 2013 [48] Tertiary hospital 
(KFSHRC) 
Comparative 
historically-controlled 
study. 24 patients 
enrolled on the active 
ASP arm and 49 
patients on the 
historical control arm 
ASP implementation 
in 2011 including 
ASP team, 
prospective audit and 
feedback, and 
education 
interventions. 
Appropriateness of 
prescribing assessed 
against formulary 
restrictions, adapted 
international infection 
guidelines. Verbal 
and written reports to 
ICU prescribers.     
Proactive core 
strategies: formulary 
restriction and pre-
approval strategies, 
prospective audit and 
feedback. 
Supplementary 
strategies: education 
interventions, 
guidelines, 
antimicrobial order 
forms, 
pharmacodynamics 
dose optimisation, 
antimicrobial cycling.  
ASP team (ID/ 
Intensivist physician 
and ASP 
pharmacists) 
Malhani et al., 2014 
[49] (conference 
poster) 
Medical City (King 
Fahad) 
Retrospective audit of 
medical records 172 
patients before ASP 
implementation and 
205 patients' post-
implementation 
Report on one ASP 
strategy 
implementation in 
hospital 
Audit and feedback to 
prescriber regarding 
IV to oral switch and 
duration of therapy 
ASP team not 
identified possibly 
including pharmacists 
Al-Somai et al., 2014 
[50] 
Tertiary hospital (King 
Abdullah Medical 
City) Makkah. 
Pre- and post-study 
to explore the impact 
of implementation of 
antimicrobial policy  
Antimicrobial policy   Antimicrobial policy 
adapted from 
international 
infectious disease 
guidelines 
clinical pharmacist, ID 
consultant 
Al-Tawfiq et al., 2015 
[51] 
Dhahran Health 
Centre 380-bed 
general hospital 
Interventional study Selective reporting of 
Gram-negative 
bacillus susceptibility 
by clinical laboratory 
services and 
pharmacy,   
considering local 
resistance rates and 
international 
guidelines.  
Education activities 
Cascade and 
restrictive reporting.         
Formulary restriction, 
guidelines and 
education activities 
Microbiologists- 
microbiology lab 
 
Al-Harthi et al., 2015 
[52] 
 
University hospitals, 
private hospitals and 
public hospitals 
 
A cross-sectional 
self-administered 
questionnaire 
  
To investigate the 
perceptions, attitude, 
and prescribing 
practice among 
clinicians about AR 
 
AlAwdah et al., 2015 
[53] (Conference 
poster) 
Tertiary hospital 
(Riyadh) 
Pilot prospective 
quality-improvement 
interventional study in 
paediatric ICU a 
Reported existence of 
ASP       Formulary 
restriction 
Formulary restriction                ASP team mentioned 
but not identified. 
Most likely including 
clinical pharmacist 
reviewing medication 
and recommending 
antimicrobial 
optimisation 
according to 
restricted formulary 
recommendations. 
Haseeb et al., 2015 
[54] (conference 
paper) 
Survey of ASPs in 
Makkah hospitals  
Survey targeting 
hospitals in Makkah 
region 
Existing elements of 
ASP 
Audit of antimicrobial 
use, education and 
training, and infection 
control and 
surveillance. Most 
common types of 
strategies were 
formulary restrictions 
for broad-spectrum 
antimicrobials and 
use of automatic stop 
orders to limit 
empirical therapy of 
antimicrobials in 
Makkah hospitals  
 
Alawi and Darwesh 
2016 [55] 
 
1002-bed tertiary 
care university 
hospital 
 
Prospective 
before/after 
 
Audit, review and 
restriction 
 
Audit and review 
Number of 
prescriptions and 
dispensations, 
incidence of Multi 
drug resistance 
(MDR) and cost 
 
Salahuddin et al., 
2016 [56] 
Specialist hospital in 
Riyadh (King Faisal 
specialist hospital) 
prospective cohort 
study 
antibiotic protocol and 
sepsis guidelines 
De-escalation 
strategy and Sepsis 
guideline adapted 
from an international 
guideline (2012) 
 
Enani, 2016 [57] Mainly in tertiary 
hospitals 
Regional survey 
targeting healthcare 
professionals in 
hospitals involving 
several GCC 
countries.  
Evidence of existing 
ASPs in tertiary care 
settings in Saudi 
Arabia.  
Although the 
definition of ASPs 
was not provided, 
restricted list of 
antimicrobial agents 
and antimicrobial 
audits were the main 
strategies reported 
 
Alshukairi et al., 2016 
[58] 
Specialist hospital 
(King Faisal specialist 
hospital,) Jeddah 
pre-post intervention 
study 
De-escalation 
protocol 
De-escalation 
protocol, education 
and training of nurses 
and physicians re 
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protocol, and auditing 
adherence to protocol 
United Arab 
Emirates 
Hashmey, 2013 [59] 
(oral presentation) 
Tawam tertiary 
hospital, National 
Oncology referral 
centre 
Report Existing functional 
ASP 
pre-approval 
antibiotics (restricted 
antimicrobials), 
guidelines and 
pathways, IT setting 
of infection control 
antibiotic stewardship 
worklist, prospective 
audit with feedback 
Microbiologists, ID 
physicians, ID 
pharmacists, Infection 
Control Practitioners 
liaising with IT and 
Quality office. 
El Hassan et al., 
2014 [60] 
Mafraq hospital, Abu 
Dhabi 
Retrospective review 
of data of 250 
patients 
Surgical antimicrobial 
prophylaxis 
guidelines 
Hospital guidelines 
on surgical 
antimicrobial 
prophylaxis and use 
of bacterial 
antibiograms 
Surgeons, clinical 
pharmacists and 
surgical nursing staff. 
Med review by 
pharmacists 
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Table 3: Identified barriers and facilitators to ASPs adoption in GCC hospitals 
Country Authors Facilitators Barriers 
Kuwait Kuwaiti Infection 
Control Directorate, 
2014 [30] 
(Government 
online report) 
Experience (in relation to age) and antibiotics 
knowledge can lead to good antimicrobial 
stewardship 
Excessive antibiotics prescribing as reported by Drs include: lack of time 
to perform the required investigation, fear of complication and antibiotic 
resistance concerns. 
Barriers to adherence to policy as reported by Drs include: non-availability 
or poor distribution of the policy, neglect of reading the policy, being 
incomplete or not updated and interrupted supply of some antibiotics. 
Knowledge of types of resistant organisms & isolation precautions 
Oman Gunn et al., 2009 
[37] 
Those hospitals that had a consistent policy and 
especially a written policy, made known to all staff, 
had better outcomes as far as post-operative 
infections 
Many health workers considered the guidelines to be out-dated 
 
Qatar Pawluk et al., 2015 
[43] 
 Non-availability of an infectious diseases specialist is the most prominent 
perceived barrier to implementation and expansion of ASP 
Training of pharmacists and pharmacy staff on elements of ASP are also 
perceived barriers. 
Saudi Arabia Al-Tawfiq et al., 
2015 [51] 
Alleviate prescribers concerns through discussing 
evidence of intervention and providing support. Held 
small group meetings with targeted (main) 
prescribers and key/ influential prescribers to 
encourage physicians to support ASP initiative 
Many physicians were comfortable only with prescribing familiar 
antibiotics, difficulty persuading physicians to prescribe specific agents/ 
combinations, relevant microbiology not always available, no incentive for 
prescribers to choose more appropriate antibiotics  
Al-Somai et al., 
2014 [50] 
 Maintaining antimicrobial control during time of Hajj in Makkah is a 
challenge because of increased number of admitted patients and 
increased antimicrobial use. 
Haseeb et al., 2015 
[54] (conference 
paper) 
 Majority of the hospitals lacked local antimicrobial guidelines based on 
hospital-wide antibiograms 
Salahuddin et al., 
2016 [56] 
 reluctance of physicians to de-escalate antimicrobial therapy in 
complicated, sicker patients with drug resistance or fungal sepsis 
Enani, 2016 [57]  Lack of programme funding and personnel as main barriers. Other 
barriers include obstruction from prescribers, and administration, lack of 
awareness of ASPs 
Alshukairi et al., 
2016 [58] 
 High resistance rates in other centres and transfer of resistance to 
specialist centres upon admission for last resort intervention 
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Table 4:  Outcomes of hospital adoption of ASPs adoption in GCC countries 
Country Authors Reduction of 
inappropriate 
prescribing 
Reduction of 
healthcare 
associated 
infections 
Reduction of 
direct 
antimicrobial cost 
Reduction of 
length of stay/ 
mortality metrics 
Reduction of 
antimicrobial 
resistance 
Reduction of 
Broad spectrum 
antibiotic use 
Bahrain Al Ansari et al., 
2013 [31] 
   Only 2 out of 101 
patients were 
admitted to hospital  
 High usage of 
Ceftriaxone  
Al Alawi et al., 
2015 [32] 
   Only 6 out of 97 
patients admitted 
to hospital 
 increased use of 
broad-spectrum 
antibiotics due to 
resistance to first 
and second line. 
World Health 
Organisation, 
2016 [34] (WHO 
report) 
    Detection and 
identification of 
AMR 
 
Oman Gunn et al., 
2009 [37] 
 Hospitals that had 
a consistent policy 
and especially 
a written policy, 
made known to all 
staff, had better 
outcomes as 
far as post-
operative infections 
    
Al-Abri et al., 
2012 [38] 
 
80% adherence to 
antimicrobial 
treatment 
guidelines of CAP 
but excessive IV 
use of macrolides 
     
Al-Maliky et al., 
2017 [40] 
     High use of broad 
spectrum 
antibiotics (90% of 
antibiotic 
prescriptions) due 
to lack of 
adherence/ 
compliance with 
guidelines and 
policy 
Qatar Khan et al., 
2010 [41] 
Adherence to 
guideline in 75% of 
cases 
     
Abdel-Aziz et 
al., 2013 [42] 
Only 40% of 
surgical patients 
received the right 
antibiotic due to 
lack of adherence 
to hospital policy.  
     
Garcell et al., 
2016 [44] 
 
     Reduction in use of 
cephalosporins but 
rise in use of other 
antibiotics such as 
oral penicillin's and 
IV macrolides. 
Garcell et al., 
2016 [45] 
Appropriate 
prescribing and 
administration of 
antibiotics 
improved 
    reduction in 
antimicrobial use 
especially 
cefuroxime 
Saudi 
Arabia 
Jacobs et al. 
2003 [46] 
eliminated 
inappropriate 
prescribing 
Reduced 
perioperative 
infective 
complications from 
32% to 11% 
    
Dib et al., 2009 
[47] 
Education and 
feedback to 
prescriber 
enhanced 
adherence to 
guidelines from 
35% to 68%. 
     
Amer et al., 
2013 [48] 
appropriate 
empirical 
antibiotics 
improved from 31% 
to 100% 
No impact on C diff 
rates 
half the total cost of 
antibacterial agents 
Reduction of 
hospital stay 376 
DDD compared to 
2404 DDD pre-
ASP. Deaths 
decreased from 
33% to 17%. 
  
Malhani et al., 
2014 [49] 
(conference 
poster) 
  Cost savings 
reported as a result 
of ASP team 
interventions 
   
Al-Somai et al., 
2014 [50] 
ASP interventions 
resulted in 37% 
reduction in 
antimicrobial 
consumptions 
 Reduction of direct 
antimicrobial cost 
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Al-Tawfiq et al., 
2015 [51] 
 Reduced C.diff 
rates 
  Reduction of 
antimicrobial 
resistance for 
some organism-
antibiotic 
combinations and 
increase in 
resistance of the 
heavily used 
antibacterial 
(piperacillin-
tazobactam) 
 
AlAwdah et al., 
2015 [53] 
(Conference 
poster) 
Improved 
antimicrobial 
prescribing in 
relation to reduced 
DOT for major 
antibiotics used. 
     
Enani, 2016 
[57] 
Two thirds report 
the outcome 
Two thirds report 
the outcome 
Two thirds report 
the outcome 
60% report the 
outcome 
55% report the 
outcome 
Two thirds report 
the outcome 
Alshukairi et al., 
2016 [58] 
    no significant effect 
on antimicrobial 
resistance 
 
United 
Arab 
Emirates 
Hashmey, 2013 
[59] (oral 
presentation) 
 reduction in c diff 40% reduction in 
consumption and 
associated costs 
 reduction in MDR reduction in use of 
broad spectrum 
antibiotics 
El Hassan et 
al., 2014 [60] 
Low adherence to 
hospital guidelines 
(32%) resulted in 
inappropriate SAP 
prescribing 
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